HCP Live

Advances in the Management of Excessive Daytime Sleepiness and Narcolepsy : Episode 6

Goals of Therapy for Narcolepsy

May 3, 2023

Michael J. Thorpy, MD
Thomas Scammell, MD

Neurology experts describe the goals of therapy for narcolepsy treatment.

EP: 1.Narcolepsy Overview

EP: 2.Burden and Risk Factor of Narcolepsy

EP: 3.Diagnosis of Narcolepsy

EP: 4.EDS Evaluation

EP: 5.Available Resources for Narcolepsy Treatment

EP: 6.Goals of Therapy for Narcolepsy

EP: 7.Pharmacological Treatment Options for Narcolepsy

EP: 8.EDS and Narcolepsy Treatment Options

EP: 9.Pitolisant: Mechanism of Action

EP: 10.Pitolisant Efficacy and Safety

EP: 11.Solriamfetol Efficacy and Safety

EP: 12.Sodium Oxybate and Antidepressants for Treatment of Cataplexy

EP: 13.Unmet Needs in Narcolepsy and Clinical Pearls

Related Videos

Related Content

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Episode 88: 2023 AAN Annual Meeting Highlights

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Episode 88: 2023 AAN Annual Meeting Highlights

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Episode 88: 2023 AAN Annual Meeting Highlights

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

Related Content

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Pimavanserin Tolerable in PSTD-Associated Insomnia, Pilot Study Suggests

Episode 88: 2023 AAN Annual Meeting Highlights

Episode 88: 2023 AAN Annual Meeting Highlights

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Low-Sodium Oxybate Remains Efficacious Regardless of Baseline Sleep Inertia

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

Episode 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

March 24th 2023

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

Once-Nightly Sodium Oxybate Shows Significant Impact on Cataplexy Attacks, Post-Hoc Analysis Shows

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

PUMAS Intervention Results in Greater Insomnia Remission Rates, Reduced Depression in Prenatal Insomnia Than CBT-I

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.